References
- Gabow PA, Grantham JJ. Schrier RW, Gottschalk CW. Polycystic kidney disease. Diseases of the kidney 1997; 6th edn. Boston USA Little Brown and Company 521 - 560
- Masoumi A, Reed-Gitomer B, Kelleher C, Bekheirnia MR, Schrier RW. Developments in the management of autosomal dominant polycystic kidney disease. Ther Clin Risk Manag 2008; 4:393 - 407
- Harris PC, Torres VE. Polycystic kidney disease. Annu Rev Med 2009; 60:321 - 337
- Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, et al. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 1996; 272:1339 - 1342
- Hanaoka K, Qian F, Boletta A, Bhunia AK, Piontek K, Tsiokas L, et al. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature 2000; 408:990 - 994
- Zhou J. Polycystins and primary cilia: primers for cell cycle progression. Annu Rev Physiol 2009; 71:83 - 113
- Koulen P, Cai Y, Geng L, Maeda Y, Nishimura S, Witzgall R, et al. Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol 2002; 4:191 - 197
- Tsiokas L, Kim S, Ong EC. Cell biology of polycystin-2. Cell Signal 2007; 19:444 - 453
- Giamarchi A, Padilla F, Coste B, Raoux M, Crest M, Honore E, et al. The versatile nature of the calcium-permeable cation channel TRPP2. EMBO Rep 2006; 7:787 - 793
- Kottgen M. TRPP2 and autosomal dominant poly-cystic kidney disease. Biochim Biophys Acta 2007; 1772:836 - 850
- Cai Y, Maeda Y, Cedzich A, Torres VE, Wu G, Hayashi T, et al. Identification and characterization of polycystin-2, the PKD2 gene product. J Biol Chem 1999; 274:28557 - 28565
- Sammels E, Devogelaere B, Mekahli D, Bultynck G, Missiaen L, Parys JB, et al. Polycystin-2 activation by inositol 1,4,5-trisphosphate-induced Ca2+ release requires its direct association with the inositol 1,4,5-trisphosphate receptor in a signaling microdomain. J Biol Chem 2010; 285:18794 - 18805
- Devogelaere B, Verbert L, Parys JB, Missiaen L, De Smedt H. The complex regulatory function of the ligand-binding domain of the inositol 1,4,5-trisphosphate receptor. Cell Calcium 2008; 43:17 - 27
- Sipma H, De Smet P, Sienaert I, Vanlingen S, Missiaen L, Parys JB, et al. Modulation of inositol 1,4,5-trisphosphate binding to the recombinant ligand-binding site of the type-1 inositol 1,4,5-trisphosphate receptor by Ca2+ and calmodulin. J Biol Chem 1999; 274:12157 - 12162
- Sienaert I, Nadif Kasri N, Vanlingen S, Parys JB, Callewaert G, Missiaen L, et al. Localization and function of a calmodulin-apocalmodulin-binding domain in the N-terminal part of the type 1 inositol 1,4,5-trisphosphate receptor. Biochem J 2002; 365:269 - 277
- Kasri NN, Bultynck G, Smyth J, Szlufcik K, Parys JB, Callewaert G, et al. The N-terminal Ca2+independent calmodulin-binding site on the inositol 1,4,5-trisphosphate receptor is responsible for calmodulin inhibition, even though this inhibition requires Ca2+. Mol Pharmacol 2004; 66:276 - 284
- Tovey SC, De Smet P, Lipp P, Thomas D, Young KW, Missiaen L, et al. Calcium puffs are generic InsP(3)-activated elementary calcium signals and are downregulated by prolonged hormonal stimulation to inhibit cellular calcium responses. J Cell Sci 2001; 114:3979 - 3989
- Bootman MD, Berridge MJ, Lipp P. Cooking with calcium: the recipes for composing global signals from elementary events. Cell 1997; 91:367 - 373
- Tovey SC, Dedos SG, Taylor EJ, Church JE, Taylor CW. Selective coupling of type 6 adenylyl cyclase with type 2 IP3 receptors mediates direct sensitization of IP3 receptors by cAMP. J Cell Biol 2008; 183:297 - 311
- Torres VE, Harris PC. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 2009; 76:149 - 168